CRL vs MAIN · rev $2.00B vs P/E 10, $5.44B cap
Charles River Laboratories (CRL) versus Main Street Capital Corporation (MAIN) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Main Street Capital Corporation (MAIN) is a asset management company listed on US.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
MAIN does not have a complete income-statement cache yet.
CRL currently screens at market cap $7.78B. MAIN currently screens at market cap $5.44B and trailing P/E 10.4.
Not investment advice. Open the CRL and MAIN stock pages for the full models.
Not investment advice.